Updates on genes related to breast cancer metastasis

Chinese Journal of Pathology

Volumn 37, Issue 4, 2008, Pages 266-269

  Liu, Bing Bing ^a   Wei, Jia ^a   Fu, Li ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; DNA; EPIDERMAL GROWTH FACTOR; EZRIN; HERMES ANTIGEN; INHIBITOR OF DIFFERENTIATION PROTEIN; MATRIX METALLOPROTEINASE; MOESIN; PROTEIN FEZ1; PROTEIN LZTS1; PROTEIN RECK; PSORIASIN; RADIXIN; REGULATOR PROTEIN; ACYLTRANSFERASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HTATIP2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN S 100; RECK PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

BREAST CANCER; DNA BINDING; GENETIC VARIABILITY; METASTASIS; REVIEW; TUMOR GENE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOPHYSIOLOGY;

ACETYLTRANSFERASES; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; S100 PROTEINS; TRANSCRIPTION FACTORS; GPI-LINKED PROTEINS;

EID: 47049096877     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Bruce B, Khanna G, Ren L, et al. Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis, 2007, 24(2):69-78.
2. Li Q, Wu MF, Song AP, et al. Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis. Ai Zheng, 2006,25(3):363-366.
3. Sarrió D, Rodríguez-Pinilla SM, Dotor A, et al. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat, 2006,98 (1):71-79.
4. Yu Y, Davicioni E, Triche TJ, et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res, 2006,66(4): 1982-1989.
5. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med, 2004,10(5):201-204.
6. Orian-Rousseau V, Chen L, Sleeman JP, et al. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev, 2002,16(23):3074-3086.
7. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and ld proteins on p16INK4a expression during cellular senescence. Nature, 2001,409(6823):1067-1070.
8. Singh J, Murata K, Itahana Y, et al. Constitutive expression of the ld-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene, 2002,21(12):1812-1822.
9. Lin CQ, Singh J, Murata K, et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res, 2000,60(5):1332-1340.
10. Fong S, Itahana Y, Sumida T, et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A, 2003,100(23):13543-13548.
11. Rudland PS, Platt-Higgins A, Renshaw C, et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res, 2000,60(6):1595-1603.
12. Chen D, Rudland PS, Chen HL, et al. Differential reactivity of the rat S100A4 (p9Ka) gene to sodium bisulfite is associated with differential levels of the S100A4 (p9Ka) mRNA in rat mammary epithelial cells. J Biol Chem, 1999,274(4):2483-2491.
13. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A, 1998,95(22):13221-13226.
14. Span PN, Sweep CG, Manders P, et al. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer, 2003,97(11):2710-2715.
15. Chang HC, Cho CY, Hung WC. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res, 2006,66(17):8413-8420.
16. Hsu MC, Chang HC, Hung WC, et al. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem, 2006,281(8):4718-4725.
17. Shtivelman E. A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene, 1997, 14(18):2167-2173.
18. Zhao J, Ni H, Ma Y, et al. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol, 2007,38(2):293-298.
19. Zhang DH, Wong LL, Tai LK, et al. Overexpression of CC3/ TIP30 is associated with HER-2/neu status in breast cancer. J Cancer Res Clin Oncol, 2005,131(9):603-608.
20. Ishii H, Baffa R, Numata SI, et al. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci U S A, 1999,96(7):3928-3933.
21. Vecchione A, Baldassarre G, Ishii H, et al. Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development. Cancer Cell, 2007,11(3):275-289.
22. Yaremko ML, Kutza C, Lyzak J, et al. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer, 1996,16(3):189-195.
23. Vecchione A, Galetti TP, Gardiman M, et al. Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urol, 2004,4:11.